279 related articles for article (PubMed ID: 17268152)
1. [Uniqueness of the mucosal immune system for the development of prospective mucosal vaccine].
Kunisawa J; Gohda M; Kiyono H
Yakugaku Zasshi; 2007 Feb; 127(2):319-26. PubMed ID: 17268152
[TBL] [Abstract][Full Text] [Related]
2. A novel mucosal vaccine targeting Peyer's patch M cells induces protective antigen-specific IgA responses.
Shima H; Watanabe T; Fukuda S; Fukuoka S; Ohara O; Ohno H
Int Immunol; 2014 Nov; 26(11):619-25. PubMed ID: 24908678
[TBL] [Abstract][Full Text] [Related]
3. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
[TBL] [Abstract][Full Text] [Related]
4. New perspectives in vaccine development: mucosal immunity to infections.
McGhee JR; Kiyono H
Infect Agents Dis; 1993 Apr; 2(2):55-73. PubMed ID: 8162356
[TBL] [Abstract][Full Text] [Related]
5. [The development of mucosal vaccine using bacterial function for targeting mucosal tissues].
Suzuki H; Kondoh M; Yagi K; Kiyono H; Kunisawa J
Yakugaku Zasshi; 2014; 134(5):629-34. PubMed ID: 24790045
[TBL] [Abstract][Full Text] [Related]
6. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut.
Shikina T; Hiroi T; Iwatani K; Jang MH; Fukuyama S; Tamura M; Kubo T; Ishikawa H; Kiyono H
J Immunol; 2004 May; 172(10):6259-64. PubMed ID: 15128814
[TBL] [Abstract][Full Text] [Related]
7. [Properties of mucosal antibodies].
Quan C; Decroix N; Bouvet JP
J Soc Biol; 2001; 195(2):119-24. PubMed ID: 11723823
[TBL] [Abstract][Full Text] [Related]
8. The common mucosal immune system: from basic principles to enteric vaccines with relevance for the female reproductive tract.
McGhee JR; Xu-Amano J; Miller CJ; Jackson RJ; Fujihashi K; Staats HF; Kiyono H
Reprod Fertil Dev; 1994; 6(3):369-79. PubMed ID: 7831485
[TBL] [Abstract][Full Text] [Related]
9. NALT- versus Peyer's-patch-mediated mucosal immunity.
Kiyono H; Fukuyama S
Nat Rev Immunol; 2004 Sep; 4(9):699-710. PubMed ID: 15343369
[TBL] [Abstract][Full Text] [Related]
10. [Recent progress for the development of mucosal vaccine].
Nochi T; Kiyono H
Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):1089-95. PubMed ID: 21089546
[No Abstract] [Full Text] [Related]
11. Targeting of mucosal vaccines to Peyer's patch M cells.
Frey A; Neutra MR
Behring Inst Mitt; 1997 Feb; (98):376-89. PubMed ID: 9382762
[TBL] [Abstract][Full Text] [Related]
12. New horizon of mucosal immunity and vaccines.
Takahashi I; Nochi T; Yuki Y; Kiyono H
Curr Opin Immunol; 2009 Jun; 21(3):352-8. PubMed ID: 19493665
[TBL] [Abstract][Full Text] [Related]
13. The mucosal immunologic network.
Bienenstock J
Ann Allergy; 1984 Dec; 53(6 Pt 2):535-40. PubMed ID: 6391284
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IgA synthesis at mucosal surfaces.
Fagarasan S; Honjo T
Curr Opin Immunol; 2004 Jun; 16(3):277-83. PubMed ID: 15134775
[TBL] [Abstract][Full Text] [Related]
15. The gastrointestinal mucosal immune system.
James SP
Dig Dis; 1993; 11(3):146-56. PubMed ID: 8370141
[TBL] [Abstract][Full Text] [Related]
16. Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies.
Shalaby WS
Clin Immunol Immunopathol; 1995 Feb; 74(2):127-34. PubMed ID: 7828366
[TBL] [Abstract][Full Text] [Related]
17. Lambda display phage as a mucosal vaccine delivery vehicle for peptide antigens.
González-Cano P; Gamage LNA; Marciniuk K; Hayes C; Napper S; Hayes S; Griebel PJ
Vaccine; 2017 Dec; 35(52):7256-7263. PubMed ID: 29153779
[TBL] [Abstract][Full Text] [Related]
18. Innate immunity in the mucosal immune system.
Nochi T; Kiyono H
Curr Pharm Des; 2006; 12(32):4203-13. PubMed ID: 17100623
[TBL] [Abstract][Full Text] [Related]
19. Induction of the mucosal immune response.
Russell MW; Mestecky J
Rev Infect Dis; 1988; 10 Suppl 2():S440-6. PubMed ID: 3055213
[TBL] [Abstract][Full Text] [Related]
20. A revisit of mucosal IgA immunity and oral tolerance.
Fujihashi K; Kato H; van Ginkel FW; Koga T; Boyaka PN; Jackson RJ; Kato R; Hagiwara Y; Etani Y; Goma I; Fujihashi K; Kiyono H; McGhee JR
Acta Odontol Scand; 2001 Oct; 59(5):301-8. PubMed ID: 11680650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
